Cited by 676Fatty Acid Research and HealthNutritional Studies and DietEdible Oils Quality and Analysis

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Open access
Hooper, Lee, Thompson, Rachel L, Harrison, Roger A, Summerbell, Carolyn D, Ness, Andy R, Moore, Helen J, Worthington, Helen V, Durrington, Paul N +5 more·2006·BMJ

Abstract

OBJECTIVE: To review systematically the evidence for an effect of long chain and shorter chain omega 3 fatty acids on total mortality, cardiovascular events, and cancer. DATA SOURCES: Electronic databases searched to February 2002; authors contacted and bibliographies of randomised controlled trials (RCTs) checked to locate studies. REVIEW METHODS: Review of RCTs of omega 3 intake for (3) 6 months in adults (with or without risk factors for cardiovascular disease) with data on a relevant outcome. Cohort studies that estimated omega 3 intake and related this to clinical outcome during at least 6 months were also included. Application of inclusion criteria, data extraction, and quality assessments were performed independently in duplicate. RESULTS: Of 15,159 titles and abstracts assessed, 48 RCTs (36,913 participants) and 41 cohort studies were analysed. The trial results were inconsistent. The pooled estimate showed no strong evidence of reduced risk of total mortality (relative risk 0.87, 95% confidence interval 0.73 to 1.03) or combined cardiovascular events (0.95, 0.82 to 1.12) in participants taking additional omega 3 fats. The few studies at low risk of bias were more consistent, but they showed no effect of omega 3 on total mortality (0.98, 0.70 to 1.36) or cardiovascular events (1.09, 0.87 to 1.37). When data from the subgroup of studies of long chain omega 3 fats were analysed separately, total mortality (0.86, 0.70 to 1.04; 138 events) and cardiovascular events (0.93, 0.79 to 1.11) were not clearly reduced. Neither RCTs nor cohort studies suggested increased risk of cancer with a higher intake of omega 3 (trials: 1.07, 0.88 to 1.30; cohort studies: 1.02, 0.87 to 1.19), but clinically important harm could not be excluded. CONCLUSION: Long chain and shorter chain omega 3 fats do not have a clear effect on total mortality, combined cardiovascular events, or cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.38755.366331.2f

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other meta-analyses suggest reduced major cardiovascular events in patients with high triglycerides and low HDL cholesterol treated with fibrates, but no decrease in cardiovascular or total mortality.

    “Results from other meta-analyses suggest reduced major CVD events in patients with high TGs and low HDL-C in fibrate-treated patients, but no decrease in CVD or total mortality [314-316].”
  • When end point measures such as cardiovascular disease are taken together in a meta-analysis, the results of omega-3 supplementation are equivocal.

    “Yet, when end point measures such as cardiovascular disease are taken together in a meta-analysis the results of omega-3 supplementation are equivocal [40,41,42,43].”

    From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R, et al. Joint British rec- ommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80:S1-29.

Cited by

Sorted by citations

Authors
Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., Riemersma, R. A., Ebrahim, S. B. J., & Smith, G. D.
Affiliations
  • University of East Anglia (GB)
  • University of Southampton (GB)
  • Teesside University (GB)
  • University of Bristol (GB)
  • University of Manchester (GB)
  • MRC Biostatistics Unit (GB)
  • Shrewsbury and Telford Hospital NHS Trust (GB)
  • University of Edinburgh (GB)
  • London School of Hygiene & Tropical Medicine (GB)
Corresponding author
Hooper, Lee
Venue
BMJ
Publisher
BMJ
Published
2006-03-24
Volume
332
Issue
7544
Pages
752-760
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2123273468
Cited by
676
References
24
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 6 · 2021: 13 · 2020: 12 · 2019: 23 · 2018: 26 · 2017: 19 · 2016: 19 · 2015: 35 · 2014: 45 · 2013: 51 · 2012: 44
FWCI
9.97
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Teesside University Research Portal (Teesside University) (publishedVersion, cc-by-nc-nd)
  • Edinburgh Research Explorer (University of Edinburgh) (acceptedVersion, other-oa)
  • Durham Research Online (Durham University) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Durham Research Online (Durham University) (submittedVersion, cc-by)
  • TeesRep (Teesside University) (submittedVersion, cc-by-nc-nd)
  • HighWire Press Open Archive (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
Keywords
omega-3 fatty acids, all-cause mortality, cardiovascular events, cancer risk, dietary supplementation, cardiovascular disease prevention
MeSH terms
Cardiovascular Diseases, Fish Oils, Humans, Neoplasms, Prognosis, Risk Factors, Cohort Studies, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review